Le Lézard
Classified in: Science and technology
Subject: PER

DXC Technology Adds Industry Veteran Cameron Art to Senior Leadership Team


Art brings more than 25 years' tech experience to DXC

ASHBURN, Va., May 1, 2024 /PRNewswire/ - DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced that Cameron Art has been appointed General Manager of the Americas and UKI markets effective May 1, 2024, reporting directly to DXC President and Chief Executive Officer Raul Fernandez.

Art will be responsible for developing the Americas and UKI growth strategy, solidifying and building deep client relationships, go-to-market strategies, and sales excellence. Art will also be leading the global strategic deals team, where he will focus on orchestrating complex, multi-year deals, increasing the breadth and depth of net new clients to drive profitable growth.

Art served in several key roles at IBM Corporation since joining the company in 1996. Most recently, he served as General Manager of IBM Americas. In addition, he has been General Manager of Industry Markets, Managing Director and Managing Partner, Enterprise Cloud Applications. He also served on the Board of Directors for IBM Japan.

Art brings a strong global perspective, as well as a technical and transformation background. He has developed go-to-market strategies and led sales execution for technology product portfolios, services, and industry solutions.

"We are very pleased to welcome Cameron, a tenured leader with a wealth of valuable experience," said Fernandez. "As we strengthen our client-centric approach with geographic market-based sales teams, his expertise will help to facilitate DXC's growth in the Americas and UKI."

Art holds a Bachelor's degree in Business from Colorado State University and studied various executive education courses at Harvard University.

Forward Looking Statements

All statements in this press release that do not directly and exclusively relate to historical facts constitute "forward-looking statements." These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. For a written description of these factors, see the section titled "Risk Factors" in DXC's upcoming Annual Report on Form 10-K for the fiscal year ended March 31, 2024, and any updating information in subsequent SEC filings. No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this report or to reflect the occurrence of unanticipated events except as required by law.

About DXC Technology

DXC Technology (NYSE: DXC) helps global companies run their mission-critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. The world's largest companies and public sector organizations trust DXC to deploy services to drive new levels of performance, competitiveness, and customer experience across their IT estates. Learn more about how we deliver excellence for our customers and colleagues at DXC.com.

SOURCE DXC Technology Company


These press releases may also interest you

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...



News published on and distributed by: